Dealing with the generic threat
September 14, 2005Sales and Marketing
The looming spectre of generics is one which no pharma company with successful medicines on the market can afford to …
Postcode prescribing down to poor financial management, says report
September 13, 2005Postcode prescribing will only be eradicated if PCTs and NHS Trusts improve their financial management, according to a new report.The …
Connecting with customers
September 13, 2005Sales and Marketing
Great creative executions, those that have the 'wow' factor and stand out from the crowd, require long-term brand strategy and …
Exubera receives FDA vote of confidence
September 9, 2005Research and Development, Sales and Marketing
Exubera, the first inhaled insulin treatment for diabetes, has moved a step closer to US approval following recommendation approval from …
Pfizer and Sanofi battle challenges on patents
September 8, 2005Sales and Marketing
Two blockbuster drugs are facing key patent challenges on both sides of the Atlantic, with the outcome of the cases …
A far stricter code – but more scope for communication too
September 8, 2005Sales and Marketing
A much tighter UK pharmaceutical industry code of practice looks set to be introduced shortly, with a broad range of …
Industry braced for new upheaval in primary care
September 8, 2005Sales and Marketing NHS, PCTs, Pfizer
Likely reductions in the number of PCTs could prove disruptive to pharmaceutical companies – but the development of another NHS …
Merck’s problems deepen as MHRA reveals investigation
September 8, 2005Sales and Marketing
The controversy around the withdrawal of Vioxx has taken a new twist with news its manufacturer is being investigated for …
Pfizer to select seven for preferred supplier list
September 8, 2005Medical Communications
Pfizer is to limit the number of healthcare agencies it works with in the UK, as it looks to streamline …
GSK acquires vaccines research and manufacturing facility
September 8, 2005Manufacturing and Production, Research and Development
GlaxoSmithKline has acquired a vaccines R&D and manufacturing facility in the US, which it will use to develop its next …
New RA drug from BMS gains recommendation
September 7, 2005Sales and Marketing
A new treatment for rheumatoid arthritis from Bristol-Myers Squibb has received recommendation approval from an FDA committee, bringing it one …
Advertising workshop
September 7, 2005Medical Communications
The investment risk in developing a profitable brand is huge and with every new brand launch comes escalating expectations. At …
The evolving world of advertising
September 6, 2005Medical Communications
The considerable challenges facing pharma companies over the past few years have taken centre stage in analysis of healthcare marketing: …
Junior doctors to be taught communication skills
September 6, 2005Newly qualified doctors will have to take a new training programme to teach them soft skills, such as how to …
Scientists back testing after guinea pig breeder forced to close
September 6, 2005Research and Development
UK scientists have rallied to support animal research after a six-year campaign against Staffordshire guinea pig breeder Darley Oaks Farm …
Pfizer demands action after more fake Lipitor found in UK
September 6, 2005Manufacturing and Production
The MHRA has discovered a second batch of counterfeit Lipitor in under a month, a worrying indication of a growing …
$1 billion Cialis closing on Viagra
September 6, 2005Sales and Marketing
Erectile dysfunction drug Cialis has achieved cumulative sales of $1 billion and is closing the gap on Pfizer's market leader …
All new product marketing to be pre-vetted in UK
September 2, 2005Medical Communications, Sales and Marketing
Advertising and marketing materials for all new products are to be vetted by the UK regulator for the accuracy of …
New NHS early warning system for long-term conditions
September 2, 2005A new computer program will give NHS clinicians an early warning about patients at risk of being admitted to hospital.The …
Latest content
